CSSi’s SPRINT72

Clinical Site Services (CSSi) is the industry leader in delivering strategic patient recruitment and enrollment solutions to study sponsors and CROs.

Blog

CSSi, 'Tis the Season for Patient Recruitment: Recruitment Strategies for Research Studies During The Holiday Season

'Tis the Season for Patient Recruitment: Recruitment Strategies for Research Studies During The Holiday Season

  • By Myra Zerr-Korolev
  • 12-Dec-2023

While the holiday hustle and bustle may be in full swing, clinical trials are at risk for delayed patient enrollment during the winter months.

A recent survey shows an estimated 84% of people plan on traveling to celebrate the holidays this year, and of those who plan on traveling, most respondents noted they are staying with either their siblings (51%) or at their parents’ house (51%).

Read More
CSSi, Patient Recruitment For Novel Therapies

Patient Recruitment For Novel Therapies

  • By Myra Zerr-Korolev
  • 26-Mar-2023

Gene and cellular therapy are novel treatment methods that are avidly being studied in a realm of different indications including oncology, neurology, rheumatology, pediatrics, and more. As of 2023, there are over 1,500 gene/cellular therapy trials actively enrolling with a majority being in Phase 1 and Phase 2 stages.

Read More
CSSi, Improving Patient Recruitment within the LGBTQIA+ Community

Improving Patient Recruitment within the LGBTQIA+ Community

  • By Myra Zerr-Korolev
  • 17-Mar-2023

LGBTQIA+ (Lesbian, Gay, Bisexual, Transgender, Queer, Intersexual, Asexual/Agender, + Additional Sexualities and Identities) make up a significant portion of the population: around 8% of the total United States population and an estimated 10% of the global population.1,2 Trends show an increased likelihood of identifying as LGBTQA+ in younger generations such as millennials and Gen Z.

Read More